These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 31959776)
1. Lithium for schizophrenia: supporting evidence from a 12-year, nationwide health insurance database and from Akt1-deficient mouse and cellular models. Luo DZ; Chang CY; Huang TR; Studer V; Wang TW; Lai WS Sci Rep; 2020 Jan; 10(1):647. PubMed ID: 31959776 [TBL] [Abstract][Full Text] [Related]
2. DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia. Blasi G; Napolitano F; Ursini G; Taurisano P; Romano R; Caforio G; Fazio L; Gelao B; Di Giorgio A; Iacovelli L; Sinibaldi L; Popolizio T; Usiello A; Bertolino A Proc Natl Acad Sci U S A; 2011 Jan; 108(3):1158-63. PubMed ID: 21187413 [TBL] [Abstract][Full Text] [Related]
3. HERV-W Envelope Triggers Abnormal Dopaminergic Neuron Process through DRD2/PP2A/AKT1/GSK3 for Schizophrenia Risk. Yan Q; Wu X; Zhou P; Zhou Y; Li X; Liu Z; Tan H; Yao W; Xia Y; Zhu F Viruses; 2022 Jan; 14(1):. PubMed ID: 35062349 [TBL] [Abstract][Full Text] [Related]
4. Behavioral phenotyping of v-akt murine thymoma viral oncogene homolog 1-deficient mice reveals a sex-specific prepulse inhibition deficit in females that can be partially alleviated by glycogen synthase kinase-3 inhibitors but not by antipsychotics. Chen YW; Lai WS Neuroscience; 2011 Feb; 174():178-89. PubMed ID: 20888398 [TBL] [Abstract][Full Text] [Related]
5. Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia. Ide M; Ohnishi T; Murayama M; Matsumoto I; Yamada K; Iwayama Y; Dedova I; Toyota T; Asada T; Takashima A; Yoshikawa T J Neurochem; 2006 Oct; 99(1):277-87. PubMed ID: 16987250 [TBL] [Abstract][Full Text] [Related]
6. Akt/GSK3 signaling in the action of psychotropic drugs. Beaulieu JM; Gainetdinov RR; Caron MG Annu Rev Pharmacol Toxicol; 2009; 49():327-47. PubMed ID: 18928402 [TBL] [Abstract][Full Text] [Related]
7. Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation. Miralem T; Lerner-Marmarosh N; Gibbs PE; Jenkins JL; Heimiller C; Maines MD FASEB J; 2016 Aug; 30(8):2926-44. PubMed ID: 27166089 [TBL] [Abstract][Full Text] [Related]
8. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Emamian ES; Hall D; Birnbaum MJ; Karayiorgou M; Gogos JA Nat Genet; 2004 Feb; 36(2):131-7. PubMed ID: 14745448 [TBL] [Abstract][Full Text] [Related]
9. Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia. Amar S; Shaltiel G; Mann L; Shamir A; Dean B; Scarr E; Bersudsky Y; Belmaker RH; Agam G Int J Neuropsychopharmacol; 2008 Mar; 11(2):197-205. PubMed ID: 17681085 [TBL] [Abstract][Full Text] [Related]
10. AKT kinase activity is required for lithium to modulate mood-related behaviors in mice. Pan JQ; Lewis MC; Ketterman JK; Clore EL; Riley M; Richards KR; Berry-Scott E; Liu X; Wagner FF; Holson EB; Neve RL; Biechele TL; Moon RT; Scolnick EM; Petryshen TL; Haggarty SJ Neuropsychopharmacology; 2011 Jun; 36(7):1397-411. PubMed ID: 21389981 [TBL] [Abstract][Full Text] [Related]
11. An emerging role for Wnt and GSK3 signaling pathways in schizophrenia. Singh KK Clin Genet; 2013 Jun; 83(6):511-7. PubMed ID: 23379509 [TBL] [Abstract][Full Text] [Related]
13. Paliperidone protects prefrontal cortical neurons from damages caused by MK-801 via Akt1/GSK3β signaling pathway. Peng L; Zhu D; Feng X; Dong H; Yue Q; Zhang J; Gao Q; Hao J; Zhang X; Liu Z; Sun J Schizophr Res; 2013 Jun; 147(1):14-23. PubMed ID: 23583326 [TBL] [Abstract][Full Text] [Related]
14. The mRNA expression of DRD2, PI3KCB, and AKT1 in the blood of acute schizophrenia patients. Liu L; Luo Y; Zhang G; Jin C; Zhou Z; Cheng Z; Yuan G Psychiatry Res; 2016 Sep; 243():397-402. PubMed ID: 27449010 [TBL] [Abstract][Full Text] [Related]
15. Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function. Balu DT; Carlson GC; Talbot K; Kazi H; Hill-Smith TE; Easton RM; Birnbaum MJ; Lucki I Hippocampus; 2012 Feb; 22(2):230-40. PubMed ID: 21049487 [TBL] [Abstract][Full Text] [Related]
17. Akting up in the GABA hypothesis of schizophrenia: Akt1 deficiency modulates GABAergic functions and hippocampus-dependent functions. Chang CY; Chen YW; Wang TW; Lai WS Sci Rep; 2016 Sep; 6():33095. PubMed ID: 27615800 [TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase 3 substrates in mood disorders and schizophrenia. Cole AR FEBS J; 2013 Nov; 280(21):5213-27. PubMed ID: 23796137 [TBL] [Abstract][Full Text] [Related]
19. AKT/SGK-sensitive phosphorylation of GSK3 in the regulation of L-selectin and perforin expression as well as activation induced cell death of T-lymphocytes. Bhavsar SK; Merches K; Bobbala D; Lang F Biochem Biophys Res Commun; 2012 Aug; 425(1):6-12. PubMed ID: 22814108 [TBL] [Abstract][Full Text] [Related]
20. Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex. Roh MS; Seo MS; Kim Y; Kim SH; Jeon WJ; Ahn YM; Kang UG; Juhnn YS; Kim YS Exp Mol Med; 2007 Jun; 39(3):353-60. PubMed ID: 17603289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]